ABSTRACT
La hepatitis es una enfermedad viral que azota a gran parte de la población mundial y cuya etiología es multifactorial, por lo que se ha clasificado a fin de hacer más conveniente su estudio de la A a la E, separándolas según sus características. Existe además la hepatitis autoinmune (HAI), entidad de etiología no conocida que gana mayor prevalencia e incidencia cada año. Se cuenta con pocos reportes en la literatura que relacionen la presentación de una hepatitis viral más una hepatitis autoinmune en un mismo paciente. Sin embargo, algunos estudios han comprobado que dicha relación es una posibilidad; lo que dificulta su orientación diagnóstica, terapéutica, tratamiento y pronóstico. Se presenta un caso de hepatitis B crónica en la que se superpuso una hepatitis autoinmune, a fin de realizar una revisión del tema y sus dificultades diagnósticas.
Hepatitis is a viral disease that affects a large portion of the world's population, which has a multifactorial etiology, thus to facilitate its study has been classified from A to E according with the characteristic. Additionally to viral hepatitis also occurs the autoimmune hepatitis, a disease of unknown etiology of which prevalence and incidence are increasing every year. There is few reports in the literature that describe the possibility of finding viral hepatitis and autoimmune hepatitis in one patient at the same time. Nevertheless some studies have indicated that there is possible correlation between them, situation that make difficult its diagnosis, therapeutic approach, treatment and prognosis. A case of chronic B hepatitis with overlapped autoimmune hepatitis is reported aiming to, get a topic review and diagnostic difficulties.
Subject(s)
Humans , Hepatitis , Communicable Diseases , Hepatitis B Antibodies , Liver DiseasesABSTRACT
Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
Subject(s)
Humans , Male , Middle Aged , Hyperamylasemia/chemically induced , Lamivudine/adverse effects , Pancreatitis/chemically induced , Reverse Transcriptase Inhibitors/adverse effects , Acute Disease , Hepatitis B, Chronic/drug therapy , Lamivudine/therapeutic use , Pancreatitis/enzymology , Reverse Transcriptase Inhibitors/therapeutic useABSTRACT
60 patients with chronic B hepatitis were treated at The Hospital No 108, using At Can Ninh, a preparation of traditional medicine. Some clinical symptoms were improved rapidly such as themia anotexia, jaundive, clark yellow urine. In comparing with control subjects, after 2-3 weeks treatment, SGOT, SGPT in blood were reduced more quickly. The preparation also reduce it Bs Ag, HBV- DNA level and serum converting rate was higher 14,3% verous 0% with p<0,05 after 3 months treatment. Some uncomfortable manifestation such as pylori pain and nausea in 2/30 patients were disappeared immediately after the cease of medicine.
Subject(s)
Hepatitis B, Chronic , Therapeutics , Medicine, TraditionalABSTRACT
This randomized, placebo-controlled clinical study evaluated the efficacy of lamivudine in 44 Vietnamese patients with histologically documented chronic hepatitis B for one-year. The patients were randomly assigned to receive 100 mg of lamivudine (22 patients) orally once daily or placebo (22 patients). The patients underwent liver biopsies before entering the study and after completing the assigned treatment regimen. At the end of therapy, the percentage of serum HBVDNA negativation was higher in the lamivudine group (86.4%) than in the control group (22% P2 points of improvement versus placebo. Lamivudine is less side effects, safety, and favorable
Subject(s)
Hepatitis B, Chronic , Lamivudine , Hepatitis B , Therapeutics , Pharmaceutical PreparationsABSTRACT
44 patients of chronic B hepatitis are divided into two groups of 22 patients. The one is treated with lamivudine (Jefflix) 100 mg daily in 12 months continuously and the other with usual vitamin and liver tonics. Results showed in 72.7% patients of lamivudine group, the indices of histological activities were improved (through Knodell score), while in controlled group – 31.8% and over the half of this group these indices worsened. Thus, lamivudine has got good effect
Subject(s)
Histological Techniques , Hepatitis B , Patients , Lamivudine , Pharmaceutical Preparations , TherapeuticsABSTRACT
0.05).There was a positive corrlation on CD40~+ and CD40L~+ in chronic B hepatitis patients.There was a positive corrlation on CD8~+/CD28~+ and CD40~+、CD40L~+ in chronic B hepatitis patients.There were no remarkable corrlation on CD8~+/CD28~- and CD40~+、CD40L~+ in chronic B hepatitis patients.Conclusion:The costimulation molecules CD40~+、CD40L~+ and CD8~+/CD28~+ are lower,while CD8~+/CD28~- are higher in chronic B hepatitis patients than in the health.To test the expression of CD40~+、CD40L~+ and CD8~+/CD28~+ on peripheral blood of the chronic B hepatitis could help to evaluate patients's celluar immunity and guide clinical treatment.
ABSTRACT
Urinary microquantitative albumin (UALb), immunoglobulin G (UIgG) ?2-microglo-bulin (U?2m), and Tamm-Horsfall protein (THP) were measured in 36 chronic B hepatitis (CHB) and 23 liver cirrhosis (LC) patients with radioimmunoassay. 109 healthy normal subjects served as controls. The results showed that the excretion of UALb was significantly increased in 17 patients. Out of 17 patients,the excretion of UIgG in 5 and U?2m in 16 were increased and the excretion of THP in 9 patients were decreased. Compared with normal controls there was a significant difference (P